In bone marrow mononuclear cells from 6 PRAME+ AML patients, in vitro treatment with chidamide upregulated PRAME mRNA expression in 5/6 bone marrow samples by around 1.5 to 138 folds. The gene discussed is PRAME; the disease is acute myeloid leukemia.